Operating
Non-cash interest expense
Insmed Non-cash interest expense increased by 0.4% to $1.38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.1%, from $1.82M to $1.38M. Over 3 years (FY 2022 to FY 2025), Non-cash interest expense shows an upward trend with a 15.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
Metric ID:
operating_amortization_of_financing_costs_and_discountsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.94M | $8.86M | $822K | $821K | $822K | $1.53M | $1.72M | $2M | $1.84M | $1.75M | $1.85M | $1.8M | $1.49M | $1.75M | $1.82M | $1.68M | $1.34M | $1.38M | $1.38M |
| QoQ Change | — | +11.6% | -90.7% | -0.1% | +0.1% | +85.6% | +13.0% | +16.2% | -8.2% | -4.8% | +5.7% | -2.8% | -17.5% | +17.7% | +4.2% | -8.0% | -19.9% | +2.5% | +0.4% |
| YoY Change | — | — | — | -89.7% | -90.7% | — | +109.7% | +144.1% | +123.8% | +14.8% | +7.4% | -10.2% | -19.3% | -0.2% | -1.6% | -6.9% | -9.6% | -21.3% | -24.1% |
Range$821K – $8.86M
CAGR-32.2%
Avg YoY Growth+8.4%
Median YoY Growth-6.9%
Current Streak2 quarters growth
Non-cash interest expense at Other Companies
Frequently Asked Questions
- What is Insmed's non-cash interest expense?
- Insmed (INSM) reported non-cash interest expense of $1.38M in Q1 2026.
- How has Insmed's non-cash interest expense changed year-over-year?
- Insmed's non-cash interest expense decreased by 24.1% year-over-year, from $1.82M to $1.38M.
- What is the long-term trend for Insmed's non-cash interest expense?
- Over 3 years (2022 to 2025), Insmed's non-cash interest expense has grown at a 15.9% compound annual growth rate (CAGR), from $3.99M to $6.22M.